Micardis Plus® Tablets for Hypertension

Micardis Plus® is a prescription tablet used to treat hypertension. It combines telmisartan with hydrochlorothiazide to lower blood pressure. This page explains approved uses, dosing basics, safety, and how to access it with US shipping from Canada, including options if buying without insurance.

What Micardis Plus Is and How It Works

CanadianInsulin.com is a prescription referral platform. We verify prescriptions with your prescriber when required, and licensed Canadian pharmacies dispense your order.

The product contains two agents. Telmisartan is an angiotensin II receptor blocker that relaxes arterial smooth muscle by blocking angiotensin II binding. Hydrochlorothiazide is a thiazide diuretic that increases sodium and chloride excretion in the distal tubule. Together, the combination reduces vascular resistance and lowers intravascular volume, which can help bring blood pressure toward target ranges. Once-daily administration supports consistent exposure across 24 hours.

This medicine is used when a single agent does not achieve the desired effect or when a prescriber prefers a fixed-dose combination. It may also replace separate components taken individually, at comparable strengths, when appropriate.

Who It’s For

This treatment is intended for adults with hypertension who may benefit from a fixed-dose ARB plus thiazide diuretic. It is not established for pediatric use in most regions. Patients who are pregnant should not use telmisartan-containing products because medicines that act on the renin-angiotensin system can cause fetal harm. Individuals with anuria or hypersensitivity to sulfonamide-derived drugs should avoid hydrochlorothiazide.

Use caution in conditions such as volume depletion, severe renal impairment, biliary obstruction, or advanced hepatic impairment. Those with gout, low sodium, or low potassium require close monitoring. For broader context on diagnosis and care pathways, see Hypertension.

Dosage and Usage

Dosing is patient-specific and follows the approved label. Fixed-dose combinations are typically taken once daily, at the same time each day, with or without food. Swallow tablets whole with water. The label generally advises correcting volume depletion before starting therapy and reassessing blood pressure after an interval determined by the prescriber.

When combination therapy is appropriate, a common initial regimen is Telmisartan Hydrochlorothiazide 40/12.5 mg once daily, with potential adjustments based on clinical response and tolerability. Do not change the dose without professional guidance. Patients using other antihypertensives, diuretics, or NSAIDs should discuss sequencing and monitoring with a clinician. For treatment overviews, the category page High Blood Pressure provides additional context.

Strengths and Forms

Film-coated tablets are commonly available in the following strength combinations. Availability can vary by dispensing pharmacy.

• 40/12.5 mg tablets
• 80/12.5 mg tablets
• Telmisartan Hydrochlorothiazide 80/25 mg tablets

Each strength contains telmisartan paired with hydrochlorothiazide at a fixed ratio. Packaging and imprint may differ by manufacturer and market. Final supply may be brand or an equivalent generic, depending on prescription and availability.

Missed Dose and Timing

If a dose is missed, take it when remembered unless the next scheduled dose is near. In that case, skip the missed dose and resume the regular schedule. Do not double doses. Taking the medicine earlier in the day may reduce sleep disruption from increased urination associated with a thiazide diuretic.

Storage and Travel Basics

Store tablets at room temperature in a dry place away from humidity. Keep the original container or blister pack closed to protect from moisture. Protect from excessive heat and direct light. Keep out of reach of children and pets. For travel, carry the labeled container and a copy of the prescription. Use a carry-on bag to maintain control over storage conditions. If using a weekly pill organizer, retain part of the labeled packaging for identification.

Benefits

This combination can simplify therapy by combining two blood pressure agents in one tablet. Once-daily dosing supports adherence. The ARB component lowers vascular tone, while the thiazide complements control through mild diuresis. The treatment may reduce the number of separate medicines required, which can help streamline routines and reduce confusion. A fixed-dose combination also limits duplication of therapy compared with taking multiple overlapping products.

Patients and prescribers may consider the ability to titrate among several dose ratios. This can support individualized care when monotherapy is not enough. Beyond convenience, the class is generally well-tolerated compared with some other antihypertensive categories, though monitoring remains essential.

Side Effects and Safety

• Dizziness or lightheadedness
• Headache or fatigue
• Increased urination
• Gastrointestinal upset
• Muscle cramps
• Photosensitivity

Important risks can include symptomatic hypotension, kidney function changes, electrolyte disturbances (such as low sodium or potassium shifts), elevated uric acid or gout, and rare hypersensitivity. Angioedema is uncommon but requires urgent care. Thiazides have been associated with acute angle-closure glaucoma in susceptible individuals; sudden eye pain or vision changes need prompt evaluation. Use is contraindicated in pregnancy; effective contraception is advised during therapy. Patients with diabetes using aliskiren should not combine these agents due to increased risks described in labeling.

Drug Interactions and Cautions

Key interactions include lithium (risk of toxicity increased with diuretics), NSAIDs (reduced antihypertensive effect and kidney risk), and other agents affecting potassium. Bile acid sequestrants such as colesevelam can lower telmisartan exposure if taken together; labels advise separation. Dofetilide is contraindicated with thiazide diuretics due to arrhythmia risk. Alcohol may enhance dizziness. Dual blockade of the renin-angiotensin system with ACE inhibitors or aliskiren increases risk of adverse renal and electrolyte effects in certain populations.

Comorbid kidney disease requires careful monitoring; see Kidney Disease for related considerations. For additional reading on cardiovascular agents, see Ramipril Uses and an overview on beta-blocker approaches in Bystolic Guide.

What to Expect Over Time

Blood pressure responses vary. Some individuals notice improved readings after steady daily use, while others require dose adjustments or an additional agent. Regular home monitoring, when advised by a clinician, can inform follow-up visits. Consistent timing, continued lifestyle measures, and medication reconciliation at each appointment can support long-term control. Report persistent dizziness, swelling, rapid weight changes, or significant changes in kidney labs to the care team promptly.

Compare With Alternatives

Several ARB/thiazide combinations are available. Generic telmisartan with hydrochlorothiazide can be an option when a prescriber targets the same class and ratios. Another alternative is valsartan paired with hydrochlorothiazide for patients who respond better to that ARB.

Consider discussing comparable combinations such as Telmisartan HCT and Diovan® HCT. Choice depends on prior response, tolerability, drug interactions, and formulary access.

Pricing and Access

Check current availability and place an order when ready. For online purchasing, many patients prefer to Buy Micardis Plus online after their prescription is verified. Orders include transparent Canadian pricing with fulfillment that Ships from Canada to US. Taxes, dispensing fees, and exact quantities depend on the pharmacy and prescription details. An encrypted checkout helps protect sensitive information.

To understand therapy options broadly, see condition resources and discuss selection with a clinician. Medication switches or substitutions require prescriber approval.

Availability and Substitutions

Supply can vary by strength. When permitted by the prescription and local laws, an equivalent generic telmisartan/hydrochlorothiazide may be dispensed. If a specific strength is unavailable, a prescriber may recommend an alternative combination or adjust components separately. Ask about the role of a Micardis Plus generic when clinically appropriate; formulations and pill appearance can differ, but active ingredients and labeled strengths match the brand.

Patient Suitability and Cost-Saving Tips

This therapy suits adults who need combination treatment and can maintain regular monitoring of blood pressure and labs. It may be less suitable when pregnancy is planned, in anuric states, or where severe hepatic impairment exists. Patients with gout or significant electrolyte disturbances may need additional caution.

To reduce out-of-pocket burden, consider multi-month supplies when allowed by the prescriber, and align refills with follow-up appointments. Set reminders to avoid gaps. Compare Canadian pricing against local options and ask about the Micardis Plus cash price at checkout when paying directly. Using a consistent pharmacy can simplify prior authorization and refill coordination.

Questions to Ask Your Clinician

• Starting goal: target blood pressure and how it will be assessed
• Monitoring plan: labs for electrolytes and kidney function
• Timing: morning vs evening dosing based on diuretic effects
• Other medicines: managing NSAIDs, lithium, or supplements
• Sun sensitivity: steps to limit photosensitivity reactions
• Pregnancy and breastfeeding: safer alternatives and timing
• Travel: packing, storage, and documentation for screening
• Next steps: when to recheck readings and follow up

Authoritative Sources

DailyMed: Telmisartan/HydrochlorothiazideHealth Canada Drug Product DatabaseBoehringer Ingelheim: Cardiovascular Medicines

Ready to proceed? Place an order for US shipping from Canada with prompt, express, temperature-controlled handling when required. This information is educational and does not replace the advice of a licensed clinician.